EPHA2 might contribute to platelet-derived growth subunit A (PDGFA) signaling transduction in combination with platelet-derived growth receptor α (PDGFRA) and mediate the resistance of glioblastoma cells to PDGFRA inhibitor.
[Signal Transduction and Targeted Therapy]